Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 6, 2026 | $1.10 | — | $4.88B | +70.4% | $0.40 |
| Q1 FY26ended Mar 31, 2026 | May 12, 2026 | $2.07 | +125.0% | $4.59B | +52.9% | $1.21 |
| Q4 FY25ended Dec 31, 2025 | — | −$1.54 | — | $2.76B | +17.3% | — |
| Q3 FY25ended Sep 30, 2025 | — | −$0.53 | — | $2.93B | +23.6% | — |
| Q2 FY25ended Jun 30, 2025 | — | −$0.89 | −545.0% | $2.86B | +32.0% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.92 | +48.4% | $3.00B | +42.9% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$0.69 | — | $2.35B | +84.1% | — |
| Q3 FY24ended Sep 30, 2024 | — | −$0.22 | — | $2.37B | +64.8% | — |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Oscar Health shares, not any token. As of Aug 6, 2026, from Massive's standardised financials and the earnings calendar.
| Q2 FY24ended Jun 30, 2024 | — | $0.20 | — | $2.17B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.62 | — | $2.10B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | −$0.66 | — | $1.28B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | −$0.29 | — | $1.44B | — | — |